The Stop CMV Act of 2025 requires hospitals and healthcare facilities to offer screening tests for congenital Cytomegalovirus (CMV) to all newborns under 21 days old. CMV is a viral infection that can be present at birth and cause serious health complications if left undetected. Each state's health chief can establish screening standards and procedures, and if a state fails to do so within two years, a federal advisory committee will set standards for the state to follow. The legislation authorizes funding through grants to states for testing administration, technical assistance, provider education, and research into improved screening methods and CMV treatments, with appropriations available for fiscal years 2025 and 2026 as deemed necessary. The National Institutes of Health is also directed to expand research on CMV screening techniques, diagnostics, prevention strategies, and vaccine development.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.